Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Meyer Andrew Hollman | Jan 2, 2025 | Sell | 5,768 | $54.5111 | $310,000 |
| Meyer Andrew Hollman | Jan 2, 2025 | Sell | 3,444 | $55.7587 | $190,000 |
| Meyer Andrew Hollman | Jan 2, 2025 | Sell | 2,922 | $53.7582 | $160,000 |
| Meyer Andrew Hollman | Jan 2, 2025 | Sell | 1,000 | $56.7778 | $57,000 |
| Meyer Andrew Hollman | Jan 2, 2025 | Sell | 200 | $57.365 | $11,000 |
| Campbell David Alan | Dec 24, 2024 | Sell | 25,000 | $56.1922 | $1.4M |
| Campbell David Alan | Dec 3, 2024 | Sell | 15,000 | $67 | $1M |
| Campbell David Alan | Nov 25, 2024 | Sell | 18,281 | $51.4322 | $940,000 |
| Campbell David Alan | Nov 25, 2024 | Sell | 6,719 | $52.0385 | $350,000 |
| Campbell David Alan | Oct 28, 2024 | Sell | 13,897 | $53.2237 | $740,000 |
| Campbell David Alan | Oct 28, 2024 | Sell | 11,103 | $53.9412 | $600,000 |
| RA Capital Healthcare Fund LP | Oct 18, 2024 | Buy | 1,200,000 | $44.75 | $54M |
| Lichter Jay | Oct 18, 2024 | Sell | 553,219 | $44.75 | $25M |
| Lichter Jay | Oct 18, 2024 | Sell | 541,824 | $44.75 | $24M |
| Lichter Jay | Oct 18, 2024 | Sell | 104,957 | $44.75 | $4.7M |
| Lichter Jay | Oct 18, 2024 | Sell | 104,892 | $50.3 | $5.3M |
| Lichter Jay | Oct 18, 2024 | Sell | 102,732 | $50.3 | $5.2M |
| Lichter Jay | Oct 18, 2024 | Sell | 19,900 | $50.3 | $1M |
| Lichter Jay | Oct 18, 2024 | Sell | 15,788 | $51.18 | $810,000 |
| Lichter Jay | Oct 18, 2024 | Sell | 15,462 | $51.18 | $790,000 |
| Lichter Jay | Oct 18, 2024 | Sell | 2,995 | $51.18 | $150,000 |
| Lichter Jay | Oct 17, 2024 | Sell | 1,843 | $50.02 | $92,000 |
| Lichter Jay | Oct 16, 2024 | Sell | 61,445 | $49.69 | $3.1M |
| Lichter Jay | Oct 16, 2024 | Sell | 60,179 | $49.69 | $3M |
| Lichter Jay | Oct 16, 2024 | Sell | 30,094 | $50.61 | $1.5M |
| Lichter Jay | Oct 16, 2024 | Sell | 29,474 | $50.61 | $1.5M |
| Lichter Jay | Oct 16, 2024 | Sell | 11,657 | $49.69 | $580,000 |
| Lichter Jay | Oct 16, 2024 | Sell | 10,957 | $50.8 | $560,000 |
| Lichter Jay | Oct 16, 2024 | Sell | 5,710 | $50.61 | $290,000 |
| Lichter Jay | Sep 30, 2024 | Sell | 958 | $46.24 | $44,000 |
| Lichter Jay | Sep 27, 2024 | Sell | 46,861 | $46.42 | $2.2M |
| Lichter Jay | Sep 27, 2024 | Sell | 45,894 | $46.42 | $2.1M |
| Meyer Andrew Hollman | Sep 27, 2024 | Sell | 50,000 | $45.9551 | $2.3M |
| Campbell David Alan | Sep 27, 2024 | Sell | 18,957 | $46.0893 | $870,000 |
| Lichter Jay | Sep 27, 2024 | Sell | 8,894 | $46.42 | $410,000 |
| Lichter Jay | Sep 27, 2024 | Sell | 1,826 | $46.19 | $84,000 |
| Lichter Jay | Sep 27, 2024 | Sell | 1,542 | $47.74 | $74,000 |
| Lichter Jay | Sep 27, 2024 | Sell | 1,511 | $47.74 | $72,000 |
| DiRaimondo Thomas | Sep 27, 2024 | Sell | 4,325 | $46.2057 | $200,000 |
| Campbell David Alan | Sep 27, 2024 | Sell | 5,248 | $46.855 | $250,000 |
| Lichter Jay | Sep 27, 2024 | Sell | 293 | $47.74 | $14,000 |
| DiRaimondo Thomas | Sep 27, 2024 | Sell | 675 | $47.2245 | $32,000 |
| Campbell David Alan | Sep 27, 2024 | Sell | 795 | $47.8384 | $38,000 |
| Lichter Jay | Sep 26, 2024 | Sell | 50,539 | $46.78 | $2.4M |
| Lichter Jay | Sep 26, 2024 | Sell | 49,497 | $46.78 | $2.3M |
| Lichter Jay | Sep 26, 2024 | Sell | 41,661 | $47.77 | $2M |
| Lichter Jay | Sep 26, 2024 | Sell | 40,803 | $47.77 | $1.9M |
| Lichter Jay | Sep 26, 2024 | Sell | 9,592 | $46.78 | $450,000 |
| Lichter Jay | Sep 26, 2024 | Sell | 7,908 | $47.77 | $380,000 |
| Lichter Jay | Sep 13, 2024 | Sell | 3,815 | $46.68 | $180,000 |
| Lichter Jay | Sep 12, 2024 | Sell | 161,356 | $47 | $7.6M |
| Lichter Jay | Sep 12, 2024 | Sell | 158,031 | $47 | $7.4M |
| Lichter Jay | Sep 12, 2024 | Sell | 30,613 | $47 | $1.4M |
| Lichter Jay | Sep 10, 2024 | Sell | 35,047 | $46.66 | $1.6M |
| Lichter Jay | Sep 10, 2024 | Sell | 34,326 | $46.66 | $1.6M |
| Lichter Jay | Sep 10, 2024 | Sell | 11,557 | $46.13 | $530,000 |
| Lichter Jay | Sep 10, 2024 | Sell | 11,319 | $46.13 | $520,000 |
| Lichter Jay | Sep 10, 2024 | Sell | 6,649 | $46.66 | $310,000 |
| Lichter Jay | Sep 10, 2024 | Sell | 2,193 | $46.13 | $100,000 |
| Lichter Jay | Sep 9, 2024 | Sell | 2,182 | $42.33 | $92,000 |
| Lichter Jay | Sep 6, 2024 | Sell | 110,644 | $42 | $4.6M |
| Lichter Jay | Sep 6, 2024 | Sell | 108,365 | $42 | $4.6M |
| Lichter Jay | Sep 6, 2024 | Sell | 20,991 | $42 | $880,000 |
| Lichter Jay | Jun 3, 2024 | Sell | 691,525 | $54.75 | $38M |
| Lichter Jay | Jun 3, 2024 | Sell | 677,279 | $54.75 | $37M |
| Lichter Jay | Jun 3, 2024 | Sell | 131,196 | $54.75 | $7.2M |
| Reardon Tighe | Jun 3, 2024 | Sell | 691,525 | $54.75 | $38M |
| Reardon Tighe | Jun 3, 2024 | Sell | 131,196 | $54.75 | $7.2M |
| Avalon Ventures XI, L.P. | Jun 3, 2024 | Sell | 691,525 | $54.75 | $38M |
| Avalon Ventures XI, L.P. | Jun 3, 2024 | Sell | 677,279 | $54.75 | $37M |
| Avalon Ventures XI, L.P. | Jun 3, 2024 | Sell | 131,196 | $54.75 | $7.2M |
| RA Capital Healthcare Fund LP | Mar 4, 2024 | Buy | 1,397,849 | $46.499 | $65M |
| Reardon Tighe | Nov 13, 2023 | Buy | 849,854 | $5.87 | $5M |
| Lichter Jay | Nov 13, 2023 | Buy | 849,854 | $5.87 | $5M |
| Avalon Ventures XI, L.P. | Nov 13, 2023 | Buy | 849,854 | $5.87 | $5M |
| RA Capital Healthcare Fund LP | Jul 19, 2023 | Buy | 503,226 | $12.459 | $6.3M |
| RA Capital Healthcare Fund LP | Jul 19, 2023 | Buy | 495,008 | $12.46 | $6.2M |
What's the latest insider transaction for Janux Therapeutics?
The most recent insider transaction for Janux Therapeutics was conducted by Meyer Andrew Hollman, who sold 5,768 shares on January 2, 2025 at a price of $54.51 per share.
Which insider bought the most JANX stock over the last two years?
RA Capital Healthcare Fund LP has bought the most JANX stock in the last 2 years, with a total value of $131M.
Which insider has sold the most JANX stock over the last two years?
Lichter Jay has sold the most JANX stock in the last 2 years, with a total value of $206M.
What is the total value of insider transactions for Janux Therapeutics (JANX) in the last 2 years?
The total value of insider transactions for Janux Therapeutics in the last 2 years is negative, amounting to -$196M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Janux Therapeutics' market confidence?
Over the last 2 years, insider transactions for Janux Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
